Cargando…
SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus with a pandemic spread. So far, a total of 349,910 SARS-CoV-2 cases and 7687 deaths were reported in Croatia. We analyzed the seroprevalence and neutralizing (NT) antibody response in the Croatian general population...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235035/ https://www.ncbi.nlm.nih.gov/pubmed/34203060 http://dx.doi.org/10.3390/pathogens10060774 |
_version_ | 1783714222352367616 |
---|---|
author | Vilibic-Cavlek, Tatjana Stevanovic, Vladimir Ilic, Maja Barbic, Ljubo Capak, Krunoslav Tabain, Irena Krleza, Jasna Lenicek Ferenc, Thomas Hruskar, Zeljka Topic, Renata Zrinski Kaliterna, Vanja Antolovic-Pozgain, Arlen Kucinar, Jasmina Koscak, Iva Mayer, Dijana Sviben, Mario Antolasic, Ljiljana Milasincic, Ljiljana Bucic, Lovro Ferencak, Ivana Kaic, Bernard |
author_facet | Vilibic-Cavlek, Tatjana Stevanovic, Vladimir Ilic, Maja Barbic, Ljubo Capak, Krunoslav Tabain, Irena Krleza, Jasna Lenicek Ferenc, Thomas Hruskar, Zeljka Topic, Renata Zrinski Kaliterna, Vanja Antolovic-Pozgain, Arlen Kucinar, Jasmina Koscak, Iva Mayer, Dijana Sviben, Mario Antolasic, Ljiljana Milasincic, Ljiljana Bucic, Lovro Ferencak, Ivana Kaic, Bernard |
author_sort | Vilibic-Cavlek, Tatjana |
collection | PubMed |
description | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus with a pandemic spread. So far, a total of 349,910 SARS-CoV-2 cases and 7687 deaths were reported in Croatia. We analyzed the seroprevalence and neutralizing (NT) antibody response in the Croatian general population after the first (May–July 2020) and second (December 2020–February 2021) pandemic wave. Initial serological testing was performed using a commercial ELISA, with confirmation of reactive samples by a virus neutralization test (VNT). A significant difference in the overall seroprevalence rate was found after the first (ELISA 2.2%, VNT 0.2%) and second waves (ELISA 25.1%, VNT 18.7%). Seropositive individuals were detected in all age groups, with significant differences according to age. The lowest prevalence of NT antibodies was documented in the youngest (<10 years; 16.1%) and the oldest (60–69/70+ years; 16.0% and 12.8%, respectively) age groups. However, these age groups showed the highest median NT titers (32–64). In other groups, seropositivity varied from 19.3% to 21.5%. A significant weak positive correlation between binding antibody level as detected by ELISA and VNT titer (rho = 0.439, p < 0.001) was observed. SARS-CoV-2 NT antibody titers seem to be age-related, with the highest NT activity in children under 10 years and individuals above 50 years. |
format | Online Article Text |
id | pubmed-8235035 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-82350352021-06-27 SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia Vilibic-Cavlek, Tatjana Stevanovic, Vladimir Ilic, Maja Barbic, Ljubo Capak, Krunoslav Tabain, Irena Krleza, Jasna Lenicek Ferenc, Thomas Hruskar, Zeljka Topic, Renata Zrinski Kaliterna, Vanja Antolovic-Pozgain, Arlen Kucinar, Jasmina Koscak, Iva Mayer, Dijana Sviben, Mario Antolasic, Ljiljana Milasincic, Ljiljana Bucic, Lovro Ferencak, Ivana Kaic, Bernard Pathogens Article Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus with a pandemic spread. So far, a total of 349,910 SARS-CoV-2 cases and 7687 deaths were reported in Croatia. We analyzed the seroprevalence and neutralizing (NT) antibody response in the Croatian general population after the first (May–July 2020) and second (December 2020–February 2021) pandemic wave. Initial serological testing was performed using a commercial ELISA, with confirmation of reactive samples by a virus neutralization test (VNT). A significant difference in the overall seroprevalence rate was found after the first (ELISA 2.2%, VNT 0.2%) and second waves (ELISA 25.1%, VNT 18.7%). Seropositive individuals were detected in all age groups, with significant differences according to age. The lowest prevalence of NT antibodies was documented in the youngest (<10 years; 16.1%) and the oldest (60–69/70+ years; 16.0% and 12.8%, respectively) age groups. However, these age groups showed the highest median NT titers (32–64). In other groups, seropositivity varied from 19.3% to 21.5%. A significant weak positive correlation between binding antibody level as detected by ELISA and VNT titer (rho = 0.439, p < 0.001) was observed. SARS-CoV-2 NT antibody titers seem to be age-related, with the highest NT activity in children under 10 years and individuals above 50 years. MDPI 2021-06-20 /pmc/articles/PMC8235035/ /pubmed/34203060 http://dx.doi.org/10.3390/pathogens10060774 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Vilibic-Cavlek, Tatjana Stevanovic, Vladimir Ilic, Maja Barbic, Ljubo Capak, Krunoslav Tabain, Irena Krleza, Jasna Lenicek Ferenc, Thomas Hruskar, Zeljka Topic, Renata Zrinski Kaliterna, Vanja Antolovic-Pozgain, Arlen Kucinar, Jasmina Koscak, Iva Mayer, Dijana Sviben, Mario Antolasic, Ljiljana Milasincic, Ljiljana Bucic, Lovro Ferencak, Ivana Kaic, Bernard SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia |
title | SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia |
title_full | SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia |
title_fullStr | SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia |
title_full_unstemmed | SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia |
title_short | SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia |
title_sort | sars-cov-2 seroprevalence and neutralizing antibody response after the first and second covid-19 pandemic wave in croatia |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235035/ https://www.ncbi.nlm.nih.gov/pubmed/34203060 http://dx.doi.org/10.3390/pathogens10060774 |
work_keys_str_mv | AT vilibiccavlektatjana sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia AT stevanovicvladimir sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia AT ilicmaja sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia AT barbicljubo sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia AT capakkrunoslav sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia AT tabainirena sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia AT krlezajasnalenicek sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia AT ferencthomas sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia AT hruskarzeljka sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia AT topicrenatazrinski sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia AT kaliternavanja sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia AT antolovicpozgainarlen sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia AT kucinarjasmina sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia AT koscakiva sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia AT mayerdijana sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia AT svibenmario sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia AT antolasicljiljana sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia AT milasincicljiljana sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia AT buciclovro sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia AT ferencakivana sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia AT kaicbernard sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia |